Title of article
Access to medicines through global health diplomacy
Author/Authors
Chattu ، Vijay Kumar Department of Occupational Science Occupational Therapy - Temerty Faculty of Medicine - University of Toronto , Singh ، Bawa Department of South and Central Asian Studies - School of International Studies - Central University of Punjab , Pattanshetty ، Sanjay Department of Global Health Governance - Prasanna School of Public Health - Manipal Academy of Higher Education , Reddy ، Srikanth School of Epidemiology and Public Health - University of Ottawa
From page
40
To page
46
Abstract
The World Health Organisation (WHO) emphasizes that equitable access to safe and affordable medicines is vital to attaining the highest possible standard of health by all. Ensuring equitable access to medicines (ATM) is also a key narrative of the Sustainable Development Goals (SDGs), as SDG 3.8 specifies access to safe, effective, quality and affordable essential medicines and vaccines for all as a central component of universal health coverage (UHC). The SDG 3.b emphasizes the need to develop medicines to address persistent treatment gaps. However, around 2 billion people globally have no access to essential medicines, particularly in lower- and middle-income countries. The states’ recognition of health as a human right obligates them to ensure access to timely, acceptable, affordable health care. While ATM is inherent in minimizing the treatment gaps, global health diplomacy (GHD) contributes to addressing these gaps and fulfilling the state’s embracement of health as a human right.
Keywords
Health equity , Access to medicines , Sustainable development goals , Global health , Diplomacy , Security measures , COVID , 19 , Vaccines , Pharmaceuticals
Journal title
Health Promotion Perspectives (HPP)
Journal title
Health Promotion Perspectives (HPP)
Record number
2743318
Link To Document